background
polymeras
chain
reaction
pcr
refer
standard
respiratori
viru
test
howev
cell
cultur
may
still
ad
valu
identifi
virus
detect
pcr
object
aim
estim
yield
clinic
impact
routin
respiratori
viru
cultur
among
children
neg
pcr
result
studi
design
retrospect
cohort
studi
perform
jan
sept
respiratori
sampl
hospit
immunocompromis
patient
year
old
routin
inocul
tradit
tube
cell
cultur
monolay
test
neg
pcr
assay
respiratori
virus
studi
patient
respiratori
specimen
neg
pcr
posit
cultur
duplic
sampl
sold
servic
exclud
data
demograph
clinic
histori
laboratori
find
patient
manag
collect
patient
chart
descript
multivari
statist
perform
result
overal
pcrneg
sampl
inocul
cell
cultur
cell
cultur
posit
met
studi
inclus
criteria
subject
hospit
mean
age
year
virus
frequent
isol
cytomegaloviru
enterovirus
cell
cultur
result
prompt
chang
manag
patient
acyclovir
initi
local
infect
four
skin
mucos
lesion
could
sampl
establish
diagnosi
conclus
children
routin
viral
cultur
respiratori
specimen
neg
pcr
low
yield
minim
clinic
impact
viral
respiratori
infect
lead
caus
hospit
acut
care
visit
antibiot
overus
children
diagnosi
confirm
identif
respiratori
viru
respiratori
specimen
tradit
diagnost
method
includ
viral
isol
cell
cultur
detect
viral
antigen
immunofluoresc
superior
sensit
molecular
method
reversetranscriptas
polymeras
chain
reaction
rtpcr
led
increas
use
clinic
laboratori
still
author
suggest
perform
viral
cultur
backup
role
respiratori
specimen
highrisk
popul
detect
virus
part
rtpcr
assay
whose
genom
mutat
may
lead
falseneg
rtpcr
result
howev
implement
second
diagnost
step
ie
viral
cultur
neg
rtpcr
result
associ
addit
cost
unknown
effect
clinic
manag
aim
estim
yield
routin
respiratori
viru
cultur
among
children
neg
pcr
describ
impact
posit
cell
cultur
result
care
perform
singlecent
retrospect
cohort
studi
montreal
children
popul
includ
patient
year
old
viral
cultur
perform
respiratori
specimen
test
neg
multiplex
pcr
duplic
sampl
exclud
viral
cultur
patient
within
day
ill
episod
respiratori
viru
specimen
submit
clinic
virolog
laboratori
test
use
laboratorydevelop
multiplex
realtim
pcr
assay
virus
influenza
ab
parainfluenza
rsv
adenoviru
coronaviru
human
metapneumoviru
enteroviru
rhinoviru
mean
turnaround
time
pcr
assay
h
respiratori
sampl
hospit
immunocompromis
patient
test
neg
pcr
routin
inocul
tradit
tube
cell
cultur
monolay
rmk
cell
line
quidel
corpor
san
diego
ca
cell
cultur
tube
observ
cytopath
effect
three
time
per
week
incub
total
day
hemadsorpt
perform
one
two
rmk
tube
day
patient
chart
review
collect
data
patient
demograph
clinic
histori
signific
underli
chronic
comorbid
medic
manag
data
analyz
use
descript
statist
addit
clinic
factor
associ
isol
respiratori
viru
compar
virus
assess
logist
regress
multivari
logist
regress
model
select
guid
akaik
inform
criterion
studi
period
respiratori
specimen
process
viral
cultur
fig
specimen
cultur
pcrand
specimen
includ
analysi
exclud
specimen
includ
duplic
sampl
sold
servic
specimen
medic
record
unavail
subject
mostli
male
hospit
tabl
sixtytwo
patient
previous
healthi
without
known
comorbid
mean
age
year
specimen
nasopharyng
sampl
work
diagnos
frequent
prompt
respiratori
viru
test
unspecifi
febril
ill
lower
respiratori
tract
infect
specimen
process
viral
cultur
without
clear
indic
mean
turnaround
time
posit
viral
cultur
result
day
tabl
virus
part
pcr
assay
compris
cultureposit
specimen
frequent
isol
virus
cytomegaloviru
enterovirus
multivari
logist
regress
analysi
factor
independ
associ
recov
respiratori
viru
cell
cultur
compar
virus
work
diagnosi
upper
lower
respiratori
tract
infect
adjust
odd
ratio
aor
ci
malign
comorbid
aor
ci
lymphopenia
aor
ci
cell
cultur
result
prompt
chang
manag
patient
posit
cultur
cultur
done
acyclovir
initi
local
infect
four
skin
mucos
lesion
could
sampl
establish
diagnosi
one
patient
immunosuppress
receiv
cytotox
chemotherapi
none
neonat
moreov
mump
report
diseas
isol
one
patient
mump
infect
suspect
commun
patient
famili
regard
cultur
result
document
instanc
manag
otherwis
affect
instanc
cessat
antibiot
discharg
hospit
initi
antivir
influenza
respiratori
virus
observ
associ
posit
viral
cultur
result
molecular
test
respiratori
virus
highli
sensit
observ
pcrneg
pediatr
respiratori
sampl
posit
cell
cultur
viru
rtpcr
panel
moreov
posit
cell
cultur
result
viru
littl
influenc
clinic
manag
diagnost
yield
viral
cultur
depend
sever
factor
includ
viral
load
qualiti
respiratori
specimen
cell
line
laboratori
staff
expertis
major
drawback
tradit
tube
cell
cultur
long
turnaround
time
take
day
week
produc
result
reason
clinic
use
techniqu
guard
result
may
arriv
late
impact
physician
decis
make
studi
patient
hsv
infect
manag
chang
due
viral
cultur
could
explain
part
shorter
time
posit
hsv
avail
specif
antivir
treatment
acyclovir
anoth
limit
viral
cultur
respiratori
virus
eg
group
c
rhinoviru
group
coxackievirus
coronavirus
polyomavirus
kiv
wuv
neither
replic
produc
identifi
cytopath
effect
standard
cell
cultur
line
viral
cultur
advantag
isol
identifi
wide
rang
virus
rather
detect
specif
viral
genet
target
rtpcr
may
import
immunocompromis
newborn
popul
viral
infect
typic
includ
respiratori
pcr
assay
cmv
hsv
may
clinic
import
moreov
infect
caus
virus
genet
mutat
may
fals
neg
pcr
viral
cultur
may
addit
advantag
public
health
level
monitor
phenotyp
antivir
suscept
inform
vaccin
develop
identifi
rare
novel
strain
limit
advantag
differ
diagnost
method
respiratori
virus
combin
method
still
recommend
author
howev
clinic
laboratori
routin
viral
cultur
pcrneg
respiratori
specimen
minim
impact
patient
care
viral
cultur
may
rare
alter
manag
aid
identifi
caus
viral
agent
certain
clinic
scenario
studi
seven
patient
work
diagnosi
mening
grew
enteroviru
nasopharyng
specimen
echoviru
coxsackieviru
three
patient
without
microbiolog
evid
bacteri
mening
one
infer
like
caus
asept
mening
enteroviru
knowledg
first
studi
evalu
impact
routin
viral
cultur
respiratori
specimen
neg
multiplex
pcr
singlecent
studi
limit
retrospect
natur
chang
patient
manag
associ
viral
cultur
result
may
well
document
medic
chart
moreov
find
may
applic
shell
vial
method
rapid
turnaround
time
compar
tradit
cultur
techniqu
nevertheless
nearli
three
year
observ
routin
tradit
viral
cell
cultur
specimen
neg
multiplex
pcr
low
yield
minim
clinic
impact
pediatr
popul
find
aid
microbiolog
lab
optim
util
respiratori
viru
test
sinc
modifi
laboratori
practic
restrict
cell
cultur
respiratori
specimen
highrisk
immunocompromis
children
upon
special
request
none
j
p
receiv
investigatoriniti
research
fund
becton
dickenson
co
serv
scientif
advisori
board
rp
diagnost
receiv
speaker
honoraria
cepheid
author
declar
compet
interest
approv
mcgill
univers
health
centr
pediatr
research
ethic
board
studi
